Science Magazine – August 4, 2020 By Jon Cohen
Designer antibodies could battle COVID-19 before vaccines arrive
Science’s COVID-19 reporting is supported by the Pulitzer Center and the Heising-Simons Foundation.
While the world is transfixed by the high-stakes race to develop a COVID-19 vaccine, an equally crucial competition is heating up to produce targeted antibodies that could provide an instant immunity boost against the virus. Clinical trials of these monoclonal antibodies, which could both prevent and treat the disease, are already underway and could produce signs of efficacy in the next few months, perhaps ahead of vaccine trials.